68Ga-Pentixafor PET/CT in vivo CXCR4 imaging for the detection of primary and recurrent glioma and its utility for response assessment to image-based radiation …

A Waheed, B Singh, R Madan, A Watts, H Singh… - 2021 - Soc Nuclear Med
47 Objectives: Glioma constitutes approximately 30% of the CNS tumours and
approximately 80% of all the malignant brain tumours. Magnetic resonance imaging (MRI) is …

68Ga-Pentixafor PET/CT offers high contrast image for the detection of CXCR4 expression in recurrent glioma.

A Watts, D Arora, N Kumar, S Thakur, R Basher… - 2019 - Soc Nuclear Med
491 Objectives: Glioma constitutes approximately 30% of the CNS tumors and
approximately 80% of all the malignant brain tumors. The median survival in high grade …

68Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary …

A Waheed, B Singh, A Watts, H Kaur… - Clinical Nuclear …, 2024 - journals.lww.com
Purpose The aim of this study was to evaluate the diagnostic potential of 68 Ga-pentixafor
PET/CT for in vivo CXCR4 receptors imaging in glioma and its possible role in response …

In vivo assessment of CXCR4 receptor expression in High-grade Glioma using [68 Ga] Ga-Pentixafor PET/CT

H Roustaei, H Vosoughi, N Norouzbeigi, K Anvari… - 2022 - Soc Nuclear Med
3112 Introduction: The tumor microenvironment determines various impacts on cancer
biology. CXC chemokine receptor type 4 (CXCR4) signaling pathway has a crucial role …

[HTML][HTML] A dataset of [68Ga] Ga-Pentixafor PET/CT images of patients with high-grade Glioma

H Roustaei, N Norouzbeigi, H Vosoughi, K Aryana - Data in Brief, 2023 - Elsevier
This paper contains single-center prospective information showing illustrative examples of
chemokine receptor-4 (CXCR4) targeting in high-grade glial brain tumors in treatment-naïve …

Assessment of optimal uptake and acquisition time for [68 Ga] Ga-pentixafor in patients with high-grade glioma

H Roustaei, H Vosoughi, N Norouzbeigi, K Anvari… - 2022 - Soc Nuclear Med
3298 Introduction: Glioma accounts for the most common primary malignant brain tumors in
adults. High-grade Glioma is known for of the most resistant-to-treatment neoplasms …

[HTML][HTML] CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather

SM Jacobs, P Wesseling, B de Keizer… - European journal of …, 2022 - Springer
Purpose CXCR4 (over) expression is found in multiple human cancer types, while
expression is low or absent in healthy tissue. In glioblastoma it is associated with a poor …

[HTML][HTML] [68Ga] Ga-Pentixafor diffuse bilateral Adrenal & Breast uptake in a patient with High-grade Glioma: A note of caution on normal variants

H Roustaei, E Askari, S Barashki, K Anvari… - Asia Oceania Journal …, 2023 - ncbi.nlm.nih.gov
Abstract [68 Ga] Ga-labeled CXC motif receptor4 as a novel radio-ligand using PET/CT has
been investigated for tracing various kinds of solid and hematopoietic malignancies in …

[HTML][HTML] Prospective study of 68Ga-NOTA-NFB: radiation dosimetry in healthy volunteers and first application in glioma patients

Z Wang, M Zhang, L Wang, S Wang, F Kang, G Li… - Theranostics, 2015 - ncbi.nlm.nih.gov
Purpose: The chemokine receptor CXCR4 is overexpressed in various types of human
cancers. As a specific imaging agent of CXCR4, 68 Ga-NOTA-NFB was investigated in this …

[PDF][PDF] Detecting CXCR4 Expression in Meningioma on 68Ga-Pentixafor PET/MRI

S Krebs, J Schwartz, C Grommes… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The CXC chemokine receptor 4 (CXCR4) is crucial for tumor proliferation, migration, and
angiogenesis in many different cancers. Recently, 68Ga-pentixafor, a radiotracer comprising …